A Study Of Daratumumab, Low-Dose Oral Dexamethasone and Cyclophosphamide With Or Without Pomalidomide
NCT03215524
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
DCdP
BIOLOGICAL:
DCd+P
Sponsor
Canadian Myeloma Research Group